Free Press Release
Create Free Account! Members Login
Art & Entertainment Automotive Blogging & Social Media Business Computer Design Education Environment Events / Trade Shows Games & Entertainment Government Health and Fitness Home & Family Industry Legal / Law Lifestyle News & Society Politics Religion Sports Technology Web sites / Internet

Press Release / Business / Frontier Pharma Market Analysis and Forecast by key Vendors, Application, Product, and Geography from 2018 to 2025

Frontier Pharma Market Analysis and Forecast by key Vendors, Application, Product, and Geography from 2018 to 2025

By Minakshi on January 01 2019 | 198 Views

ResearchMoz presents this most up-to-date research on “Frontier Pharma Market Size and Share 2018 Sales, Production, Consumption and Segmentation”.

Schizophrenia is a chronic mental disorder that affects 1% of the population - equivalent to 51 million people worldwide - and is ranked among the top 10 causes of disability in developed countries. It is a debilitating condition that affects those afflicted, their families and society as a whole. In 2013, the direct and indirect cost of schizophrenia to US society was estimated to be $155 billion. Despite this, the schizophrenia pipeline is relatively small. This is indicative of a low level of R&D funding and investment in schizophrenia, most likely due to a poor understanding of the underlying mechanisms of the disease, which hinders the development of effective pharmaceutical drugs.
Request a Sample PDF Report: https://www.researchmoz.us/enquiry.php?type=S&repid=1821759
There are marketed pharmaceutical products that are effective in treating the positive symptoms of schizophrenia, but none are available for the treatment of negative and cognitive symptoms. There is no single pharmacological drug that addresses all the symptoms of schizophrenia, and therefore it is likely that in the future combined treatments based on pharmacogenetics will be used to provide a tailored approach. As such there is a strong rationale for continued R&D investment in schizophrenia therapeutics, due to the high levels of unmet need across a large population. This report assesses first-in-class innovation across the schizophrenia pipeline.
View Complete TOC with Tables and Figures index at: https://www.researchmoz.us/frontier-pharma-schizophrenia-diverse-first-in-class-pipeline-shows-promise-for-treatment-of-negative-and-cognitive-symptoms-report.html/toc
About Us
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators. 
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
tmrresearchblog.com



Latest Exclusive Press Release
XDR Market key Players Analysis, Applications, Forecasts to 2027
9 Best Vitamin and Mineral Supplements That Can Help Boost Your Immune System and Overall Health
Selective Laser Sintering Equipment Market by Manufacturer and Regions 2023
Generative Design Market Size Analysis | Autodesk, Altair, ANSYS, MSC Software
7 Things To Remember When Looking For The Best Commerical Cleaning Services For Your Business
Popular Press Release
A New Website Launches for Registereds to Apply, Find, and Interview for RN Travel Jobs in California
Zeng Fanzhi Parcours Exhibition 2016 in Beijing
Home Ministry’s Population Register Worse than Prisoner Identification
High Demand for a Computer Information Systems Degree
Feel-planet.com Has Made It Possible to Discover the Wonders of the World Online


Art & Entertainment Automotive Blogging & Social Media Business
Computer Design Education Environment
Events / Trade Shows Games & Entertainment Government Health and Fitness
Home & Family Industry Legal / Law Lifestyle
News & Society Politics Religion Sports
Technology Web sites / Internet